Orbital invasion despite topical anti-metabolite therapy for conjunctival carcinoma.
Two cases of conjunctival carcinoma developed orbital invasion during treatment with topical medication. This was a retrospective study from a tertiary ophthalmic oncology unit, performed after informed consent was obtained. The main outcome measurement was orbital invasion. Two patients treated with topical agents developed orbital invasion. While topical agents are important in treatment of conjunctival neoplasia, recurrence or deep invasion require careful monitoring.